Peerspectrum

Clinical research with Psychedelic compounds like psilocybin, LSD and MDMA have gotten a lot of press recently. Major institutions such as Johns Hopkins, UCLA and Yale are leading the charge with dramatic results in drug addiction, PTSD, end of life care, depression and other mental illness that is simply breathtaking. When we think back to the psychedelic sixties, it’s hard to imagine that legitimate clinical research was taking place with psychedelics then, too; although much of it (think Timothy Leary) wouldn’t pass even the most lenient institutional review boards today. Much of this early research in the US came to a screeching halt with the passage of the Controlled Substances Act of 1970. Only now are we beginning to reawaken to the incredible healing and trans-formative effects these compounds can offer. Today it’s our distinct privilege to speak with the researcher who carried the torch through a time when psychedelic research was nearly non-existent. When it comes to the mechanisms of action, bio